創薬の世界市場2019-2027

Inkwood Researchが発行した調査報告書(DATA9090684)
◆英語タイトル:GLOBAL DRUG DISCOVERY MARKET FORECAST 2019-2027
◆商品コード:DATA9090684
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2019年8月
◆ページ数:167
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
EnterprisewideUSD4,500 ⇒換算¥504,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGSThe global drug discovery market is expected to rise at a CAGR of 8.54% during the forecast period of 2019-2027. In terms of revenue, the global market accounted for $XX million in 2018 and is estimated to reach $83155 million by 2027. The market is primarily driven by factors like rising incidences of chronic diseases across the globe and increasing government funding to various research & development programs.
MARKET INSIGHTS
The global drug discovery market is classified into several segments, such as technology, services, end-users, and drug type. The applications of small molecule drugs in the treatment of chronic disorders is primarily surging the demand for drugs in the market. The rising technological developments and innovations are fueling the drug discovery market at a significant pace. Also, many drug manufacturers, government, and private players are investing in the research & development activities, which further enlarge the global drug discovery market.
REGIONAL INSIGHTS
North America, Asia-Pacific, Europe and Rest of World are the geographical segments of the drug discovery market. By the end of the forecast period, the North American market is anticipated to account for the lion’s share of the global market. The U.S is expected to be one of the major contributors to this region owing to high healthcare spending and growing lifestyle-related diseases. Also, the Asia-Pacific market is predicted to register the fastest growth driven by high investments and growing R&D.
COMPETITIVE INSIGHTS
Noted players in the global drug discovery market include AstraZeneca PLC, Pfizer Inc., 3M Company, Antares Pharma, Becton, Dickinson & Company (BD), Eli Lily, Johnson and Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Boehringer Ingelheim, Novartis, Merck & Co. Inc., Sanofi, and GlaxoSmithKline LLC.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS
3.2.2. IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS
3.2.3. BIOINFORMATICS IS THE WIDELY USED DRUG DISCOVERY TECHNOLOGY
3.2.4. SMALL MOLECULE DRUG TYPE CONSTITUTES THE HIGHEST MARKET SHARE
3.2.5. CONTRACT RESEARCH ORGANIZATIONS (CROS) ARE THE FASTEST-GROWING END USER
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. AGING POPULATION
4.2.2. BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST COMPARED TO GENERIC DRUGS
4.2.3. GROWING HEALTHCARE EXPENDITURE
4.2.4. GLOBAL INCREASE IN LIFESTYLE ORIENTED DISEASES & FATALITIES
4.2.5. TECHNOLOGICAL ADVANCEMENT
4.3. MARKET RESTRAINTS
4.3.1. DELAY IN PRODUCT LAUNCHES
4.3.2. POOR ACCESS TO HEALTHCARE SERVICES IN DEVELOPING MARKETS
4.3.3. SHIFT FROM BRANDED TO GENERIC DRUGS
4.4. MARKET OPPORTUNITIES
4.4.1. EXTENSIVE R & D FOR NEW PRODUCT LAUNCHES
4.4.2. INCREASING DEMAND FOR SPECIALTY MEDICINES
4.4.3. RISING INVESTMENT BY PHARMACEUTICAL COMPANIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
4.5. MARKET CHALLENGES
4.5.1. COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES
4.5.2. STRINGENT GOVERNMENT REGULATIONS
5. MARKET BY TECHNOLOGY
5.1. HIGH THROUGHPUT SCREENING
5.2. BIOCHIPS
5.3. BIOINFORMATICS
5.4. PHARMACOGENOMICS AND PHARMACOGENETICS
5.5. COMBINATORIAL CHEMISTRY
5.6. NANOTECHNOLOGY
5.7. SPECTROSCOPY
5.8. METABOLOMICS
5.9. OTHER TECHNOLOGIES
6. MARKET BY DRUG TYPE
6.1. SMALL MOLECULE DRUG
6.2. BIOLOGIC DRUG
7. MARKET BY SERVICE
7.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
7.2. CHEMICAL SERVICES
7.3. BIOLOGICAL SERVICES
7.4. OTHER PHARMACEUTICAL SERVICES
8. MARKET BY END USER
8.1. RESEARCH INSTITUTES
8.2. PHARMACEUTICAL COMPANIES
8.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.4. OTHER END USER
9. KEY ANALYTICS
9.1. PORTER’S FIVE FORCES MODEL
9.1.1. THREATS OF NEW ENTRANTS
9.1.2. THREAT OF SUBSTITUTE PRODUCTS
9.1.3. BARGAINING POWER OF BUYERS
9.1.4. BARGAINING POWER OF SUPPLIERS
9.2. COMPETITIVE RIVALRY
9.3. VALUE CHAIN ANALYSIS
9.4. PESTLE ANALYSIS
9.5. REGULATORY FRAMEWORK
9.6. OPPORTUNITY MATRIX
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. THE UNITED STATES
10.1.2. CANADA
10.2. EUROPE
10.2.1. THE UNITED KINGDOM
10.2.2. FRANCE
10.2.3. GERMANY
10.2.4. SPAIN
10.2.5. ITALY
10.2.6. REST OF EUROPE
10.3. ASIA PACIFIC
10.3.1. CHINA
10.3.2. INDIA
10.3.3. JAPAN
10.3.4. SOUTH KOREA
10.3.5. AUSTRALIA
10.3.6. REST OF ASIA PACIFIC
10.4. REST OF WORLD
10.4.1. LATIN AMERICA
10.4.2. MIDDLE EAST AND AFRICA
11. COMPANY PROFILES
11.1. 3M COMPANY
11.2. ANTARES PHARMA
11.3. ASTRAZENECA PLC
11.4. BAYER AG
11.5. BECTON, DICKINSON & COMPANY (BD)
11.6. BOEHRINGER INGELHEIM
11.7. ELI LILY
11.8. F. HOFFMANN-LA ROCHE LTD
11.9. GLAXOSMITHKLINE LLC
11.10. JOHNSON AND JOHNSON
11.11. MERCK & CO. INC.
11.12. NOVARTIS
11.13. PFIZER, INC.
11.14. SANOFI

LIST OF TABLES
TABLE 1 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 2 FACT SHEET OF GLOBAL FATALITIES
TABLE 3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
TABLE 4 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 5 GLOBAL BIOCHIPS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 6 GLOBAL BIOINFORMATICS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 7 GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 8 GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 9 GLOBAL NANOTECHNOLOGY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 10 GLOBAL SPECTROSCOPY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 11 GLOBAL METABOLOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 12 GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 13 GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)
TABLE 14 GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 15 GLOBAL BIOLOGIC DRUG MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 16 GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)
TABLE 17 GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 18 GLOBAL CHEMICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 19 GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 20 GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 21 GLOBAL DRUG DISCOVERY MARKET, BY END USER, 2019-2027 ($ MILLION)
TABLE 22 GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 23 GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 24 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 25 GLOBAL OTHER END USER MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 26 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 27 NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 28 EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 30 REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)

LIST OF FIGURES
FIGURE 1 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL DRUG DISCOVERY MARKET, SHARE BY TECHNOLOGY 2018 & 2027 (%)
FIGURE 3 GLOBAL DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)
FIGURE 6 GLOBAL DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL DRUG DISCOVERY MARKET, SHARE BY DRUG TYPE 2018 & 2027 (%)
FIGURE 13 GLOBAL DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL DRUG DISCOVERY MARKET, SHARE BY SERVICE 2018 & 2027 (%)
FIGURE 16 GLOBAL DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL DRUG DISCOVERY MARKET, SHARE BY END USER 2018 & 2027 (%)
FIGURE 21 GLOBAL DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL DRUG DISCOVERY MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)
FIGURE 25 PORTER’S FIVE FORCE MODEL
FIGURE 26 GLOBAL DRUG DISCOVERY MARKET, REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 27 THE UNITED STATES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 28 CANADA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 29 THE UNITED KINGDOM DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 30 FRANCE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 31 GERMANY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 32 SPAIN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 33 ITALY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 34 REST OF EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 35 CHINA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 36 INDIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 37 JAPAN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 38 SOUTH KOREA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 39 AUSTRALIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 40 REST OF ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 41 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES
TABLE 1 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 2 FACT SHEET OF GLOBAL FATALITIES
TABLE 3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
TABLE 4 GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 5 GLOBAL BIOCHIPS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 6 GLOBAL BIOINFORMATICS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 7 GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 8 GLOBAL COMBINATORIAL CHEMISTRY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 9 GLOBAL NANOTECHNOLOGY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 10 GLOBAL SPECTROSCOPY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 11 GLOBAL METABOLOMICS MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 12 GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 13 GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)
TABLE 14 GLOBAL SMALL MOLECULE DRUG MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 15 GLOBAL BIOLOGIC DRUG MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 16 GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)
TABLE 17 GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 18 GLOBAL CHEMICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 19 GLOBAL BIOLOGICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 20 GLOBAL OTHER PHARMACEUTICAL SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 21 GLOBAL DRUG DISCOVERY MARKET, BY END USER, 2019-2027 ($ MILLION)
TABLE 22 GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 23 GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 24 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 25 GLOBAL OTHER END USER MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 26 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
TABLE 27 NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 28 EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 30 REST OF WORLD DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)


LIST OF FIGURES
FIGURE 1 GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL DRUG DISCOVERY MARKET, SHARE BY TECHNOLOGY 2018 & 2027 (%)
FIGURE 3 GLOBAL DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)
FIGURE 6 GLOBAL DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL DRUG DISCOVERY MARKET, SHARE BY DRUG TYPE 2018 & 2027 (%)
FIGURE 13 GLOBAL DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL DRUG DISCOVERY MARKET, SHARE BY SERVICE 2018 & 2027 (%)
FIGURE 16 GLOBAL DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL DRUG DISCOVERY MARKET, SHARE BY END USER 2018 & 2027 (%)
FIGURE 21 GLOBAL DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL DRUG DISCOVERY MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)
FIGURE 25 PORTER’S FIVE FORCE MODEL
FIGURE 26 GLOBAL DRUG DISCOVERY MARKET, REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 27 THE UNITED STATES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 28 CANADA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 29 THE UNITED KINGDOM DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 30 FRANCE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 31 GERMANY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 32 SPAIN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 33 ITALY DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 34 REST OF EUROPE DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 35 CHINA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 36 INDIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 37 JAPAN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 38 SOUTH KOREA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 39 AUSTRALIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 40 REST OF ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 41 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)


【掲載企業】

1. 3M COMPANY
2. ANTARES PHARMA
3. ASTRAZENECA PLC
4. BAYER AG
5. BECTON, DICKINSON & COMPANY (BD)
6. BOEHRINGER INGELHEIM
7. ELI LILY
8. F. HOFFMANN-LA ROCHE LTD
9. GLAXOSMITHKLINE LLC
10. JOHNSON AND JOHNSON
11. MERCK & CO. INC.
12. NOVARTIS
13. PFIZER, INC.
14. SANOFI



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 創薬の世界市場2019-2027(GLOBAL DRUG DISCOVERY MARKET FORECAST 2019-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆